A Comparative Study on the Efficacy and Safety of Dose Escalation of Luseogliflozin in Type 2 Diabetes Mellitus Patients With Poor Glycemic Control.

Arao, Tadashi; Okada, Yosuke; Kurozumi, Akira; Tanaka, Yoshiya

Arao, Tadashi; Okada, Yosuke; Kurozumi, Akira; Tanaka, Yoshiya.

Afiliação

Arao T; Department of Internal Medicine of Diabetes, Metabolism and Endocrinology and Hematology and Collagen Disease, Japan Labour Health and Safety Organization Kyushu Rosai Hospital, Moji Medical Center, Kitakyushu, JPN.
Okada Y; First Department of Internal Medicine, School of Medicine, University of Occupational and Environmental Health, Kitakyushu, JPN.
Kurozumi A; First Department of Internal Medicine, School of Medicine, University of Occupational and Environmental Health, Kitakyushu, JPN.
Tanaka Y; First Department of Internal Medicine, School of Medicine, University of Occupational and Environmental Health, Kitakyushu, JPN.

Cureus ; 15(2): e35393, 2023 Feb.

Article em En | MEDLINE | ID: mdl-36846645

Palavras-chave

dose- dependency; hemoglobin a1c (hba1c); luseogliflozin; sodium-glucose cotransporter 2 (sglt2) inhibitors; type 2 diabetes mellitus (t2dm)

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Clinical_trials Idioma: En Revista: Cureus Ano de publicação: 2023 Tipo de documento: Article País de publicação: Estados Unidos

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google